Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach

Total article views   HTML views PDF downloads Totals
5,980 Dovepress* 5,466+ 1,101 6,567
PubMed Central* 514 173 687
Totals 5,980 1,274 7,254
*Since 16 April 2020

View citations on PubMed Central and Google Scholar